Verification study on the immunomodulatory effects of continuous consumption of dairy products: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Verification study on the immunomodulatory effects of continuous consumption of dairy products

Meiji Co., Ltd0 sites140 target enrollmentJanuary 12, 2024

ConditionsHealthy adult

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy adult
Sponsor: Meiji Co., Ltd
Enrollment: 140
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 12, 2024

End Date

April 14, 2024

Last Updated

last year

Study Type

Interventional

Sex

All

Investigators

Sponsor

Meiji Co., Ltd

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\.Subjects suffering from, undergoing treatment for, or with a history of diabetes, renal or hepatic disease, heart disease or other serious illness, thyroid disease, adrenal disease, or other metabolic diseases. 2\.Subjects with chronic diseases and use drug regularly. 3\.Subjects with a history or current history of drug or alcohol dependence. 4\.Subjects who have been regularly using (more than three days a week) food containing lactic acid bacteria such as yogurt, lactic acid bacteria beverages, food for specified health uses, food with nutrient function claims, health food or supplements. 5\.Subjects whose average daily alcohol consumption exceeds 40 g per day (1,000 mL of alcohol drink at 5% alcohol). 6\.Subjects who are unable to abstain from alcohol for one day prior to each inspection day. 7\.Subjects who have habit of smoking. 8\.Subjects who have hay fever. 9\.Subjects with a history of gastrointestinal diseases affecting digestion and absorption and gastrointestinal surgery (except appendicitis). 10\.Subjects with dental or oral problems that involve bleeding and are the symptoms likely to continue during the study period. 11\.Subjects who scheduled for vaccination during the study period. 12\.Subjects whose hemoglobin levels are below 12 g/dl for male and 11 g/dl for female in the blood test at the time of the screening test. 13\.Subjects who test positive for infectious diseases at the time of the screening test. 14\.Subjects who are pregnant, planning or wishing to be pregnant during the study period, and are breastfeeding. 15\.Subjects prone to diarrhea when consuming dairy products. 16\.Subjects with food allergy. 17\.Subjects who have participated in other clinical studies in the month prior to the screening test, and plan or wish to participate in other clinical studies during the study period. 18\.Subjects who are judged as unsuitable for this study by the investigator for other reasons.